Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Summer B Gibson

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Neurology|December 6, 2013
Familial clustering of ALS in a population-based resourceSummer B Gibson, Karla P Figueroa, Mark B Bromberg, et al.
Neurology|June 24, 2017
The evolving genetic risk for sporadic ALSSummer B Gibson, Jonathan M Downie, Spyridoula Tsetsou, et al.
Neurology|May 13, 2016
Population-based risks for cancer in patients with ALSSummer B Gibson, Diana Abbott, James M Farnham, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 28, 2015
Relationship of creatine kinase to body composition, disease state, and longevity in ALSSummer B Gibson, Edward J Kasarskis, Nan Hu, et al.
Neurology|June 17, 2021
Pathogenic Effect of <i>TP73</i> Gene Variants in People With Amyotrophic Lateral SclerosisKristi L Russell, Jonathan M Downie, Summer B Gibson, et al.
The Lancet. Neurology|September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trialPedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Neuron|March 24, 2018
Genome-wide Analyses Identify KIF5A as a Novel ALS GeneAude Nicolas, Kevin P Kenna, Alan E Renton, et al.
JAMA Neurology|August 30, 2021
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral SclerosisJanel O Johnson, Ruth Chia, Danny E Miller, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Neurology|December 6, 2013
Familial clustering of ALS in a population-based resourceSummer B Gibson, Karla P Figueroa, Mark B Bromberg, et al.
Neurology|June 24, 2017
The evolving genetic risk for sporadic ALSSummer B Gibson, Jonathan M Downie, Spyridoula Tsetsou, et al.
Neurology|May 13, 2016
Population-based risks for cancer in patients with ALSSummer B Gibson, Diana Abbott, James M Farnham, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 28, 2015
Relationship of creatine kinase to body composition, disease state, and longevity in ALSSummer B Gibson, Edward J Kasarskis, Nan Hu, et al.
Neurology|June 17, 2021
Pathogenic Effect of <i>TP73</i> Gene Variants in People With Amyotrophic Lateral SclerosisKristi L Russell, Jonathan M Downie, Summer B Gibson, et al.
The Lancet. Neurology|September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trialPedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Neuron|March 24, 2018
Genome-wide Analyses Identify KIF5A as a Novel ALS GeneAude Nicolas, Kevin P Kenna, Alan E Renton, et al.
JAMA Neurology|August 30, 2021
Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral SclerosisJanel O Johnson, Ruth Chia, Danny E Miller, et al.
Pageof 1